Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

D. Ross Camidge; Eudocia Q. Lee; Nancy U. Lin; Kim Margolin; Manmeet Ahluwalia; Martin Bendszus; Susan M. Chang; Janet Dancey; Elisabeth G.E. de Vries; Gordon J. Harris; F. Stephen Hodi; Andrew B. Lassman; David R. Macdonald; David Marc Peereboom; David Schiff; Ricardo Soffietti; Martin J. van den Bent; Jeffrey S. Wefel; Patrick Y. Wen

doi:10.1016/S1470-2045(17)30693-9

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

D. Ross Camidge, Eudocia Q. Lee, Nancy U. Lin, Kim Margolin, Manmeet Ahluwalia, Martin Bendszus, Susan M. Chang, Janet Dancey, Elisabeth G.E. de Vries, Gordon J. Harris, F. Stephen Hodi, Andrew B. Lassman, David R. Macdonald, David Marc Peereboom, David Schiff, Ricardo Soffietti, Martin J. van den Bent, Jeffrey S. Wefel, Patrick Y. Wen

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Lancet Oncology
Volume	19
DOIs	https://doi.org/10.1016/S1470-2045(17)30693-9
State	Published - Jan 1 2018

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1016/S1470-2045(17)30693-9License: Unspecified

Cite this

Camidge, D. R., Lee, E. Q., Lin, N. U., Margolin, K., Ahluwalia, M., Bendszus, M., Chang, S. M., Dancey, J., de Vries, E. G. E., Harris, G. J., Hodi, F. S., Lassman, A. B., Macdonald, D. R., Peereboom, D. M., Schiff, D., Soffietti, R., van den Bent, M. J., Wefel, J. S., & Wen, P. Y. (2018). Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncology, 19. https://doi.org/10.1016/S1470-2045(17)30693-9

Camidge, DR, Lee, EQ, Lin, NU, Margolin, K, Ahluwalia, M, Bendszus, M, Chang, SM, Dancey, J, de Vries, EGE, Harris, GJ, Hodi, FS, Lassman, AB, Macdonald, DR, Peereboom, DM, Schiff, D, Soffietti, R, van den Bent, MJ, Wefel, JS & Wen, PY 2018, 'Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.', Lancet Oncology, vol. 19. https://doi.org/10.1016/S1470-2045(17)30693-9

@article{5ddc90386f03497c96694fc91c2e206d,

title = "Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.",

author = "Camidge, \{D. Ross\} and Lee, \{Eudocia Q.\} and Lin, \{Nancy U.\} and Kim Margolin and Manmeet Ahluwalia and Martin Bendszus and Chang, \{Susan M.\} and Janet Dancey and \{de Vries\}, \{Elisabeth G.E.\} and Harris, \{Gordon J.\} and Hodi, \{F. Stephen\} and Lassman, \{Andrew B.\} and Macdonald, \{David R.\} and Peereboom, \{David Marc\} and David Schiff and Ricardo Soffietti and \{van den Bent\}, \{Martin J.\} and Wefel, \{Jeffrey S.\} and Wen, \{Patrick Y.\}",

note = "Patients with active CNS disease are often excluded from clinical trials, and data regarding the CNS efficacy of systemic agents are usually obtained late in the drug development process or not at all.",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/S1470-2045(17)30693-9",

language = "American English",

volume = "19",

journal = "Lancet Oncology",

}

TY - JOUR

T1 - Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

AU - Camidge, D. Ross

AU - Lee, Eudocia Q.

AU - Lin, Nancy U.

AU - Margolin, Kim

AU - Ahluwalia, Manmeet

AU - Bendszus, Martin

AU - Chang, Susan M.

AU - Dancey, Janet

AU - de Vries, Elisabeth G.E.

AU - Harris, Gordon J.

AU - Hodi, F. Stephen

AU - Lassman, Andrew B.

AU - Macdonald, David R.

AU - Peereboom, David Marc

AU - Schiff, David

AU - Soffietti, Ricardo

AU - van den Bent, Martin J.

AU - Wefel, Jeffrey S.

AU - Wen, Patrick Y.

N1 - Patients with active CNS disease are often excluded from clinical trials, and data regarding the CNS efficacy of systemic agents are usually obtained late in the drug development process or not at all.

PY - 2018/1/1

Y1 - 2018/1/1

UR - https://mdanderson.elsevierpure.com/en/publications/clinical-trial-design-for-systemic-agents-in-patients-with-brain-

U2 - 10.1016/S1470-2045(17)30693-9

DO - 10.1016/S1470-2045(17)30693-9

M3 - Article

VL - 19

JO - Lancet Oncology

JF - Lancet Oncology

ER -

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Disciplines

Access to Document

Other files and links

Cite this